NCT07397351: Aroxxen® Inhalation for Cardioprotection After Elective PCI With Stent Implantation
- State
- Under way
- Phase
- Phase 2
- People
- 180 planned
- Started
- 5 Mar 2026
- Primary completion
- 1 Oct 2026
- Arms
- Aroxxen® Inhalation, Composition Variant 1, Aroxxen® Inhalation, Composition Variant 2
- Results
- None posted
- 9 Feb 2026: Trial registered
- 5 Mar 2026: Trial started